Introduction
Pheochromocytomas are uncommon tumors of the adrenal glands (small triangular-shaped glands located on top of kidneys), characterized by the excessive production of catecholamines (a type of neurohormone - a chemical made by nerve cells). Surgical removal of these tumors, known as pheochromocytoma surgery, remains the primary treatment modality. Pheochromocytomas can result in increased blood pressure (hypertension) in approximately 1 in 500 people. It is seen in both genders equally. It mostly affects individuals in the age group of 30 to 65 years of age. This article further discusses the advancements in surgical techniques, perioperative management, and long-term outcomes associated with pheochromocytoma surgery.
Prevalence
-
PCC affects approximately one to two per 1000 people.
-
PCC is responsible for causing hypertension in about 1 in every 500 adults.
What Are the Indications of Pheochromocytoma Surgery?
The indications of the surgery are:
-
Episodic headaches.
-
Excessive sweating (diaphoresis).
-
Rapid or increased heart rate (tachycardia).
These three classical symptoms (triad) presented by patients give alarming signs for early intervention and surgery.
Preoperative Preparation:
Preoperative (before operation) management aims to stabilize the blood flow (hemodynamics), prevent catecholamine secretion during the procedure, and minimize perioperative (during operation) complications. Alpha-adrenergic blockade with Phenoxybenzamine or Doxazosin is initiated several weeks before surgery to prevent hypertensive crises (sudden severe rise in blood pressure). Beta-adrenergic blockade may be added to control increased heart rate (tachycardia). Volume expansion with intravenous (IV) fluids is crucial to maintain intravascular volume (volume within the blood vessels and lymphatic fluid) and prevent hypotension during tumor manipulation.
What Are the Different Approaches Used For Pheochromocytoma Surgery?
The choice of surgical approach for adrenal tumors is determined by various factors such as the size and location of the tumor, the appearance of the tumor on the radiograph, history of abdominal surgery, as well as the surgeon's level of experience. The surgery is usually performed under general anesthesia, or epidural anesthesia can be administered.
Open adrenalectomy (removal of the adrenal gland through one surgical cut in the front of the abdomen), performed via a transabdominal (through the abdominal wall), is considered the gold standard approach. However, in cases of large or invasive tumors (which tend to spread or have malignant potential), open surgery may be necessary to ensure complete resection and minimize complications. Hence, the selection of the surgical approach requires careful consideration of the individual patient's circumstances, as well as the surgeon's expertise and experience.
Different alternative surgical approaches used are:
-
Robotic-Assisted Surgery: Robotic-assisted surgery has emerged as a promising option in minimally invasive adrenal surgery, offering enhanced precision and maneuverability for complex cases, although evidence regarding outcomes compared to laparoscopy is still evolving. Further studies are needed to see the effectiveness of robotic-assisted surgery in pheochromocytoma surgery.
-
Partial Adrenalectomy: In select cases where preserving adrenal function is paramount, partial adrenalectomy (removing a part of the adrenal gland) may be considered, particularly for bilateral (affecting both sides) pheochromocytomas or patients with a solitary (single) adrenal gland.
-
The Mini Back Scope Adrenalectomy (MBSA): This technique is one of the best surgical options for pheochromocytoma surgery, according to the research. The advantage of this procedure is it has a minimal loss of blood during the surgery and less dissection (separation of muscle layers during surgery) needed. This surgical technique is mostly done by skilled surgeons, and it has less of a chance of damaging the underlying nerves and vessels.
What Are the Advancements in Pheochromocytoma Surgical Technique?
The following are the advances in pheochromocytoma surgical techniques:
-
Minimally Invasive Technique: Laparoscopic (a thin tube attached with a tiny camera) adrenalectomy - a surgical procedure to remove the adrenal gland (is increasingly preferred for most cases, as it offers comparable outcomes with reduced (long-term suffering from disease) morbidity, shorter hospital stays, and faster recovery.
-
Selective Venous Sampling: Preoperative imaging techniques, such as selective venous sampling (a quick and reliable method to detect parathyroid hormone by collection of blood samples), aid in localizing the tumor and assessing its vascular supply. This information helps surgeons plan the optimal surgical approach and minimize the risk of intraoperative bleeding and post-operative surgical complications.
-
Intraoperative Monitoring: Real-time intraoperative monitoring of BP (blood pressure) and catecholamine levels is crucial for the management of hypertensive crises during tumor manipulation. Advanced monitoring techniques, including intra-arterial blood pressure monitoring and continuous catecholamine assays, enable prompt intervention and enhance patient safety.
What Are the Complications Associated with Pheochromocytoma Surgery?
Although rare, a few complications associated with pheochromocytoma surgery are:
-
Hemorrhage (excessive bleeding).
-
Injury to surrounding and underlying vital structures, such as nerves and vessels, leads to numbness in the area.
-
Persistent hypertension (increased blood pressure) may occur.
-
Hypoglycemia (decreased blood sugar levels). Regular checks of blood sugar levels are advised after the surgery.
What Are the Long-Term Clinical Outcomes Associated with Pheochromocytoma Surgery?
The pheochromocytoma surgery carries a greater risk. The clinical outcomes associated with pheochromocytoma surgery are:
-
Tumor Recurrence Surveillance: Long-term surveillance strategies, including biochemical testing and radiographic imaging studies, are essential for detecting tumor recurrence or metastasis (spread to other organs). Periodic follow-up assessments enable early intervention and improve long-term outcomes for patients undergoing pheochromocytoma surgery.
-
Quality of Life: Surgical resection of pheochromocytomas significantly improves patients' quality of life (QoL) by alleviating symptoms of catecholamine excess, such as hypertension, palpitations, and sweating. Multidisciplinary care, including psychological support and lifestyle modifications, further enhances patients' well-being and functional outcomes.
Future Perspective
-
Genetic Screening: With increasing recognition of hereditary predisposition to pheochromocytoma, genetic screening and counseling play a pivotal role in identifying at-risk individuals and guiding surveillance and management strategies.
-
Targeted Therapies: Emerging molecular targets and novel treatment modalities, including tyrosine kinase inhibitors and peptide receptor radionuclide therapy, hold promise for patients with advanced or metastatic disease not amenable to surgical resection.
Conclusion
Advancements in surgical techniques, perioperative management, and long-term surveillance have revolutionized the management of pheochromocytomas. Surgical resection stands as the cornerstone in the treatment paradigm for pheochromocytoma, a rare but potentially life-threatening neuroendocrine tumor. Through meticulous preoperative preparation, careful intraoperative management, and vigilant postoperative care, surgeons can navigate the challenges posed by catecholamine excess and ensure favorable outcomes for patients. Nonetheless, ongoing research and multidisciplinary collaboration are essential to refine treatment approaches further and enhance long-term outcomes for individuals with this complex condition.
